Follow
Nicola Pietrafusa
Nicola Pietrafusa
Verified email at opbg.net
Title
Cited by
Cited by
Year
Characterisation of CASPR2 deficiency disorder-a syndrome involving autism, epilepsy and language impairment
P Rodenas-Cuadrado, N Pietrafusa, T Francavilla, A La Neve, P Striano, ...
BMC medical genetics 17, 1-7, 2016
842016
Claustrum damage and refractory status epilepticus following febrile illness
S Meletti, J Slonkova, I Mareckova, G Monti, N Specchio, P Hon, ...
Neurology 85 (14), 1224-1232, 2015
662015
Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease
N Specchio, M Bellusci, N Pietrafusa, M Trivisano, L de Palma, ...
Epilepsia 58 (8), 1380-1388, 2017
652017
New‐onset refractory status epilepticus and febrile infection‐related epilepsy syndrome
N Specchio, N Pietrafusa
Developmental Medicine & Child Neurology 62 (8), 897-905, 2020
582020
Changing times for CLN2 disease: the era of enzyme replacement therapy
N Specchio, N Pietrafusa, M Trivisano
Therapeutics and clinical risk management, 213-222, 2020
492020
Defining the electroclinical phenotype and outcome of PCDH19‐related epilepsy: A multicenter study
M Trivisano, N Pietrafusa, A Terracciano, C Marini, D Mei, F Darra, ...
Epilepsia 59 (12), 2260-2271, 2018
492018
Autism and epilepsy in patients with tuberous sclerosis complex
N Specchio, N Pietrafusa, M Trivisano, R Moavero, L De Palma, A Ferretti, ...
Frontiers in Neurology 11, 542221, 2020
482020
Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series
S Partemi, MC Vidal, P Striano, O Campuzano, C Allegue, M Pezzella, ...
International journal of legal medicine 129, 495-504, 2015
452015
Neuronal ceroid lipofuscinosis: potential for targeted therapy
N Specchio, A Ferretti, M Trivisano, N Pietrafusa, C Pepi, C Calabrese, ...
Drugs 81, 101-123, 2021
442021
Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real‐world study
N Specchio, N Pietrafusa, V Doccini, M Trivisano, F Darra, F Ragona, ...
Epilepsia 61 (11), 2405-2414, 2020
402020
PCDH19-related epilepsy and Dravet syndrome: face-off between two early-onset epilepsies with fever sensitivity
M Trivisano, N Pietrafusa, V di Ciommo, S Cappelletti, L de Palma, ...
Epilepsy Research 125, 32-36, 2016
382016
Cannabidiol treatment for refractory epilepsies in pediatrics
U Raucci, N Pietrafusa, MC Paolino, G Di Nardo, MP Villa, P Pavone, ...
Frontiers in Pharmacology 11, 586110, 2020
372020
Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy
M Trivisano, A Terracciano, T Milano, S Cappelletti, N Pietrafusa, ...
Epilepsia 56 (5), e53-e57, 2015
352015
Outcome after hemispherotomy in patients with intractable epilepsy: comparison of techniques in the Italian experience
L de Palma, N Pietrafusa, F Gozzo, C Barba, G Carfi-Pavia, M Cossu, ...
Epilepsy & Behavior 93, 22-28, 2019
312019
Impact of COVID-19 pandemic on pediatric patients with epilepsy–The caregiver perspective
M Trivisano, N Specchio, N Pietrafusa, C Calabrese, A Ferretti, R Ricci, ...
Epilepsy & Behavior 113, 107527, 2020
292020
Results from an Italian expanded access program on cannabidiol treatment in highly refractory Dravet syndrome and Lennox–Gastaut syndrome
LF Iannone, G Arena, D Battaglia, F Bisulli, P Bonanni, A Boni, ...
Frontiers in Neurology 12, 673135, 2021
262021
Imbalance of systemic redox biomarkers in children with epilepsy: role of ferroptosis
S Petrillo, N Pietrafusa, M Trivisano, C Calabrese, F Saura, MG Gallo, ...
Antioxidants 10 (8), 1267, 2021
242021
Source of cannabinoids: what is available, what is used, and where does it come from?
N Specchio, N Pietrafusa, HJ Cross
Epileptic Disorders 22, S1-S9, 2020
242020
Purified cannabidiol for treatment of refractory epilepsies in pediatric patients with developmental and epileptic encephalopathy
N Pietrafusa, A Ferretti, M Trivisano, L De Palma, C Calabrese, ...
Pediatric Drugs 21, 283-290, 2019
232019
Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: a systematic review and individual …
R Stevelink, D Al-Toma, FE Jansen, HJ Lamberink, AA Asadi-Pooya, ...
EClinicalMedicine 53, 2022
202022
The system can't perform the operation now. Try again later.
Articles 1–20